85 results about "Insulin pump" patented technology

The invention discloses a remote warning and monitoring system and method for an insulin pump, and relates to the technical field of medical equipment monitoring, and the system comprises a data collection module which is used for obtaining multi-modal physiological and equipment data from user side equipment in real time; the risk assessment engine is used for performing fusion analysis based on the multi-modal physiological and equipment data to generate a comprehensive risk assessment result; the dynamic early warning module is used for dynamically triggering warning information of different risk levels according to the comprehensive risk assessment result; the remote communication module is used for simultaneously pushing the warning information to at least one remote monitoring terminal and user side equipment; and the remote intervention interface is integrated on the remote monitoring terminal and is used for receiving and displaying the warning information and enabling a remote guardian to initiate at least one intervention instruction. Alarm omission caused by the fact that a patient is alone or the response ability is limited is effectively avoided; the accuracy and reliability of risk assessment are improved, and false alarms are reduced; the risk response time is shortened, and the safety of patients is guaranteed.

The invention discloses an insulin pump safety reminding system based on remote communication, and the system comprises an insulin pump terminal which is used for collecting equipment operation parameters, and receiving and executing a verified operation instruction; the patient monitoring terminal is bridged with a data transfer interface, a local data encryption cache interface, a graded early warning display interface and a remote man-machine interaction interface of the insulin pump terminal and the hospital comprehensive management platform; the graded authorization user terminal receives early warning information related to the insulin pump terminal, checks the state of a patient and initiates a remote operation request; the hospital comprehensive management platform is in communication connection with each terminal, manages each terminal, performs data aggregation and intelligent analysis, generates early warning information based on a multi-dimensional rule, and performs authority management and auditing and multi-source data fusion application; and the safety communication and control module is used for guaranteeing data transmission safety, operation instruction compliance and system emergency fault-tolerant operation. According to the invention, cross-time-space safety protection and active early warning can be realized, the treatment safety and management efficiency are improved, and the method is suitable for medical and pension institutions at all levels.

The invention provides an intelligent insulin closed-loop infusion system for type 1 diabetes mellitus, and relates to the technical field of diabetes mellitus treatment equipment. The system comprises a blood glucose monitoring module, a control module, an insulin infusion module, a user interaction module, a wireless communication module and a power module, and closed-loop precise infusion of insulin is achieved through cooperation of the multiple modules. Wherein a closed-loop algorithm based on a dynamic basic rate formula is arranged in the control module, and the insulin infusion amount can be dynamically adjusted in combination with an LSTM blood glucose prediction model and a metabolic parameter least square method updating unit; the insulin infusion module adopts a micro peristaltic pump controlled by PWM (Pulse Width Modulation) and a current monitoring type blockage detection unit, so that the infusion precision and safety are guaranteed. According to the system, the blood glucose standard reaching time proportion can be increased to 78%, the hypoglycemia occurrence frequency is reduced to 0.8 times per week, the system is remarkably superior to a traditional insulin pump and a simple closed-loop system, meanwhile, the system has the advantages of being long in sensor service life and low in power consumption, and the treatment convenience and safety of type 1 diabetes patients are improved.

The invention relates to the technical field of intelligent medical monitoring, and discloses a critical patient blood glucose monitoring and risk intervention system based on artificial intelligence. The system comprises a multi-source physiological data integration module, a risk map construction module, an intervention decision generation module and an intervention execution control module. The system integrates and standardizes physiological data from the continuous blood glucose monitor and the multi-parameter monitoring equipment; the physiological parameters are mapped into pathological nodes based on the medical knowledge map, and the activation probability of the pathological nodes is calculated to construct an individualized risk map, so that systematic risk assessment is realized. Further, in combination with individual information of the patient, performing multi-objective optimization on the intervention strategy by applying a simulated annealing algorithm to generate an optimal decision; and analyzing the decision into a control instruction to drive the insulin pump to execute precise intervention. According to the invention, the crossing from passive alarm to active risk prediction and personalized intervention is realized, and the safety and accuracy of blood glucose management of critical patients are improved.

The invention relates to the technical field of insulin pumps, in particular to a simple needle assisting module for an insulin pump, which comprises a bottom shell, and a fluid pushing module, a percutaneous insertion module and a reciprocating driving module which are arranged in the bottom shell, a mounting groove is formed in the bottom shell, the reciprocating driving module comprises a torsion spring, a guide block and a driving block, and the torsion spring has pre-torsion amount; one end of the torsion spring extends outwards and forms a connecting arm, a first limiting groove and a second limiting groove are formed in the installation groove, a strip-shaped groove is formed in the guide block, the driving block comprises a first sliding block used for fixing a needle body and a second sliding block used for fixing a sleeve, the guide block is arranged above the torsion spring, and the connecting arm of the torsion spring is movably arranged in the strip-shaped groove of the guide block. And in the process that the torsional spring releases the pre-torsion amount, the connecting arm drives the guide block to move in the mounting groove in the insertion or retraction direction. The insulin pump achieves needle assisting operation through cooperation of the extension arm at the end of the torsional spring and the guide block, and is simple in structure, convenient to install, good in stability and low in cost.

The invention relates to the technical field of medical instruments, and discloses a small insulin pump with an insulin depletion reminding function, which comprises a shell, a medicine storage tube is inserted into a bottom cavity of the shell, a piston I is inserted into one end of the medicine storage tube, a push rod I is inserted into one end of the piston I, and a motor is mounted at the top of the cavity. A motor is arranged in the shell, a lead screw is connected to the output end of the motor, a vibration ringing mechanism is arranged on the top of the motor, and a battery bin is arranged on the top in the shell. By arranging the vibration ringing mechanism, a daytime pure vibration insulin depletion reminding mode and a night sound vibration composite insulin depletion reminding mode can be flexibly switched according to use scenes; in addition, the reminding intensity is dynamically changed along with the stock of the liquid medicine, and a progressive reminding mechanism with an extremely strong warning effect is achieved.

This invention discloses a novel centralized remote insulin infusion management method and system, relating to the field of diabetes telemedicine technology. The invention employs a dual-platform architecture separating monitoring and intervention, with the cloud server and dedicated monitoring station as independent cloud subsystems. A persistent WebSocket connection is established between the cloud and the execution terminal to complete identity verification and communication key negotiation. Remote commands are sequentially checked for legality and concurrent conflicts, and command issuance is controlled by a distributed concurrent lock at specified time intervals to prevent deadlock. After completing local security verification, the execution terminal forwards the command to the insulin pump, synchronizing the execution status to the cloud and management terminal in real time, achieving closed-loop control throughout the entire process. This invention significantly improves the real-time performance and security of remote insulin infusion, overcoming the shortcomings of traditional SMS remote control solutions, such as cumbersome processes, unreliable communication, and inability to adapt to centralized management.

The invention discloses an alarm device of an insulin pump in a magnetic resonance examination scene, and relates to the technical field of medical instruments, the alarm device comprises a pumping mechanism, the pumping mechanism comprises a shell, the inner wall of the shell is fixedly connected with a medicine feeding cylinder and a battery, and the shell is internally provided with an alarm mechanism; the alarm mechanism comprises a magnetic field alarm unit, the magnetic field alarm unit is arranged in the shell, the magnetic field alarm unit is used for detecting a magnetic field in a magnetic resonance examination scene and giving an alarm, the alarm mechanism further comprises an alarm auxiliary unit, and the alarm auxiliary unit is arranged in the magnetic field alarm unit. The alarm device for the insulin pump in the magnetic resonance examination scene can give an alarm in time after a patient wears the insulin pump to enter the magnetic resonance examination scene, so that data disorder or loss caused by damage of electronic components in the insulin pump due to the fact that the patient wears the insulin pump to carry out magnetic resonance examination is avoided; and the use safety and reliability of the insulin pump are effectively improved.

The invention discloses a miniature insulin pump and system suitable for children and active groups, and belongs to the technical field of insulin pumps, the miniature insulin pump comprises an insulin pump body, and the two ends of the insulin pump body are connected with watchbands used for being worn by the children and the active groups; the insulin pump body comprises a shell, the interior of the shell comprises a cavity layer, a power storage layer and a control layer, the cavity layer is used for containing an injection hose and an injection needle which are sealed after disinfection, and the power storage layer comprises an insulin storage bin, a power bin and an electric power bin which are sequentially arranged; a control circuit board is arranged in the control layer; isolation absorption structures for absorbing leaked insulin are arranged between the layers and between the bins; the insulin storage tank and the micro infusion pump are connected through a magnetic suction circulation connector structure, and the micro infusion pump and the injection hose are connected through a magnetic suction circulation connector structure. The problems that an existing insulin pump is not designed for children and active groups, so that the carrying adaptability is poor, and the liquid leakage risk is high can be solved.

Systems, computer programs, devices, and methods that enable coordination across multiple devices of the mobile ecosystem. In one embodiment, smart glasses detect when a user is about to eat food or take a drink and capture the consumable and portion. The data is recorded in a "morsel track" for health activity analysis. Low-fidelity captures provide preliminary recognition, while higher-fidelity captures are selectively invoked for definitive classification. Machine-learning logic generates predicted metabolic responses, such as real-time glucose trends, based on the recorded events. Predicted responses may dynamically adjust the operation of continuous glucose monitors, heart-rate sensors, or other biomedical devices. In some embodiments, the system triggers a pharmaceutical dispenser, such as an insulin pump, inhaler, or transdermal patch, to provide closed-loop therapeutic intervention in real time.

An insulin delivery system for diabetes management includes a patch-based insulin pump configured to deliver insulin to a user, a user input button disposed on the patch-based insulin pump, a processor configured to execute a hybrid closed loop algorithm that automatically controls insulin delivery based on glucose levels. The user input button is configured to receive user input comprising a sequence of button presses that communicate contextual information about user activities to the hybrid closed loop algorithm, the contextual information being distinct from direct insulin bolus delivery commands. The contextual information may include meal intake, physical activity, and sleep status communicated through different sequences of button presses. The system includes confirmation mechanisms that provide feedback and allow cancellation of inputs, enabling discrete real-time communication of personalized data to enhance diabetes management.

A method of determining an insulin bolus to be administered by an insulin delivering device is disclosed. According to the inventive method, glucose measurement data corresponding to glucose level measurement signals detected by a continuous glucose sensor are received. An insulin bolus to be administered by the insulin delivering device is determined based on a formula having expressions indicative of, for example, glucose level derived from the glucose measurement data, carbohydrate-to-insulin ratio (CIR) and an insulin sensitivity factor (ISF). The method can be carried out using a processor of a device such as insulin pen, an insulin pump, a remote control device configured to remotely control an insulin pump or an insulin pen, a continuous glucose meter, a controller of a continuous glucose meter, a blood glucose meter, and a portable electronic device such as a smart phone, smart watch or tablet.

A medical device and method for determining a basal dose of insulin and a bolus dose of insulin to be administered for glycemic control is provided. The medical device includes an insulin pump, a control interface including a button configured to select one of a plurality of present bolus insulin doses based on input from a user (e.g., a patient), and a controller configured for executing instructions to determine a basal insulin delivery rate based, at least in part, on a total daily basal insulin dose and to determine the plurality of preset bolus insulin doses based, at least in part, on a total daily bolus insulin dose.

1. The name of the design product: insulin pump (endocrinology). 2. The use of the design product: for continuous subcutaneous infusion of insulin. 3. The design points of the design product: in the combination of shape and color. 4. The picture or photo that best indicates the design points: perspective view 1. 5. The design for which protection is sought includes color. 6. Other circumstances that need to be explained: the appearance of the shell is made of smooth plastic material, with partial reflection effect.

The present invention relates to the technical field of medical instruments. Disclosed are a power device and a patch insulin pump. The power device comprises a power output module, a transmission assembly, a lead screw and a sliding block. The power output module comprises a power output shaft that is in transmission connection with the transmission assembly. The transmission assembly is in transmission connection with the lead screw, and is configured such that the power that is output by the power output shaft is transmitted to the lead screw so as to drive the lead screw to rotate around its own axis. The sliding block is sleeved on the lead screw, and abuts against the end of a push rod away from a drug-delivery piston. When the lead screw rotates around its own axis, the sliding block is driven to move relative to the lead screw along the axis of the lead screw, so that the sliding block drives the push rod to move along the axis of the lead screw. The axis of the power output shaft is parallel to the axis of the lead screw, and the power output direction of the power output shaft is opposite to the moving direction of the sliding block. The power device disclosed in the present invention is conducive to reducing the volume of the patch insulin pump.

The application discloses an insulin pump double-channel precision infusion driving device, which comprises a base and a cover plate matched with the base, and further comprises two groups of storage barrels for storing insulin, the piston parts of the two groups of storage barrels are connected with the base through sliding assemblies, and the piston parts drive the insulin in the storage barrels when the sliding assemblies work; variable speed assemblies for driving the sliding assemblies to move are arranged in the base, the two groups of variable speed assemblies are connected with the sliding assemblies at corresponding positions respectively, and the variable speed assemblies are connected with the driving motor in the base. Through the design of the electric and manual double-mode driving, the six-gear variable speed adjusting mechanism is combined, the automatic and accurate infusion demand in the daily scene is met, the emergency infusion can be realized through the manual operation when the electric mode fails or there is no power supply, and the reliability and scene adaptability of the equipment use are remarkably improved.

The utility model discloses an insulin pump wearing packaging bag which comprises a placing bag and a fixing belt, openings are formed in the left side and the right side of the placing bag and the upper side of the placing bag, a circle of zipper is arranged on the opening of the placing bag, two zipper heads are arranged on the zipper, and the front side wall face of the placing bag is arranged to be a perspective cotton yarn net face. Two clamping belts are arranged on the upper portion and the lower portion of the rear side of the containing bag, the two clamping belts and the rear side wall face of the containing bag form a small closed ring, the fixing belt penetrates through the small closed ring, and the two ends of the fixing belt are connected into a ring through hook-and-loop fasteners; according to the insulin pump placing bag, the front side face of the placing bag is arranged to be of the perspective cotton yarn net face structure, after an insulin pump is placed in the placing bag, the numerical value and other conditions of the insulin pump can be directly observed from the outside, in addition, keys of the insulin pump can be directly operated through the cotton yarn net face on the front side, and use convenience is improved.

The invention relates to the technical field of fluid pumps, in particular to an auxiliary liquid filling method of a fluid pump, which is particularly suitable for an adhesion type insulin pump without a clutch mechanism. The device comprises a pump body mounting position with an inclined surface, and the pump body mounting position is used for obliquely placing the fluid pump and enabling a liquid outlet of a liquid bag in the fluid pump to be positioned at a high position; the communication interface is arranged at the pump body mounting position and is used for establishing communication connection with a driving module of the fluid pump; and the control module is electrically connected with the communication interface and is configured to send a driving instruction to the driving module through the communication interface so as to start the driving module to work, so that the gas accumulated at the high position of the liquid bag is preferentially discharged. A physical slope is combined with active electric control, gas-liquid separation is achieved through gravity, the driving module is intelligently controlled to complete precise exhaust, and therefore the function that the fluid pump without the clutch mechanism can be normally used after being filled with any dosage is achieved.

1. The name of the design product: insulin pump. 2. The use of the design product: for patients to inject insulin. 3. The design features of the design product: in shape. 4. The picture or photo that best shows the design features: perspective view.

The two-stage slow-release control method of insulin pump injection specifically comprises the following steps: (1) the injection end of the two-stage slow-release insulin patch pump is attached to the skin of the designated area of the human body; (2) the detection mechanism collects the blood glucose concentration and body temperature data of the human body in real time; (3) the insulin pump is started, and the insulin liquid is pumped into the shell according to the injection amount and speed set by the artificial medical order; (4) the flow control of the insulin liquid is realized through the control circuit module, the piezoelectric ceramic mechanism and the flow control mechanism; (5) the insulin liquid is injected into the human body subcutaneously from top to bottom through the injection mechanism; (6) after the insulin liquid is injected, the two-stage slow-release insulin patch pump is removed. The present application can monitor the blood glucose concentration and body temperature of the human body in real time, provide technical support for safe injection, realize two-stage slow-release of the insulin liquid, and realize partition control of the injection of the insulin liquid according to the needs, thereby preventing the occurrence of sudden situations.

The utility model relates to insulin pump fixing technical field discloses dynamic insulin pump fixing support, including organism, the rear side fixed connection of organism has the waistband, the rear side left and right side top of waistband all fixedly connected with the shoulder belt, the tail end of two shoulder belts all fixedly connected with the fixed buckle, the left and right side bottom of two fixed buckles all slide connection has the buckle, the adjacent side of multiple buckles all fixedly connected with the spring, the adjacent side middle part of multiple buckles all fixedly connected with the steel wire, the top of two steel wires all fixedly connected with the slide buckle, the rear side installation of waistband has the convenient adjusting mechanism. In the utility model, the fixed buckle is inserted into the groove on the waistband after the shoulder belt passes the shoulder, the buckle is popped out to be fixed by the spring at this moment, to this avoid the waistband to slide down when moving, the buckle is retracted by the steel wire to pull the slide buckle by pulling up, to this fixed buckle is pulled out from the waistband and then takes off dynamic insulin pump fixing support.

The invention relates to an insulin pump for supplying medicine through a magnetic control capsule robot. The insulin pump comprises an implantable main body and the magnetic control capsule robot which can be taken orally and is filled with an insulin medicament, the implantable main body comprises a sealed shell, and a magnetic control module, a puncture module, a storage and transportation module and a power supply module which are integrated in the sealed shell. When the magnetic control capsule robot arrives near the right curve of the colon of the right inferior belly along the digestive tract, the magnetic control module of the implantable main body adsorbs and fixes the magnetic control capsule robot through magnetism; the puncture module punctures a shell of the magnetic control capsule robot through a puncture needle to establish a medicine channel; the storage and delivery module extracts insulin in the magnetic control capsule robot through negative pressure and stores the insulin, and then the insulin is pumped into the abdominal cavity of a patient through the piezoelectric micropump. According to the intraperitoneal infusion system, long-term wound opening caused by traditional in-vitro infusion is avoided for a type I diabetes patient needing to continuously supply insulin in a mode of orally taking the magnetic control capsule robot, non-invasive and accurate intraperitoneal infusion of insulin is achieved, and the wound infection risk of the type I diabetes patient can be remarkably reduced.

The invention relates to the technical field of insulin pump fixing application, in particular to an insulin pump fixing and protecting device which comprises a bonding layer, a bottom film and a film-covering patch, the insulin pump fixing and protecting device can effectively prevent water from entering through matched sealing of the bottom film and the film-covering patch, and even when a patient takes a bath or swims, the insulin pump fixing and protecting device cannot be damaged. The insulin pump can also be well protected, and the situation that equipment is damaged or normal work of the insulin pump is affected due to water contact is avoided. A patient does not need to take off the insulin pump before taking a bath or swimming, operation troubles are reduced, meanwhile, stimulation and damage possibly caused to the skin due to frequent taking off and wearing of the insulin pump are reduced, and the convenience for the patient to wear the insulin pump is improved. In addition, due to the good sealing performance of the device, external dust, bacteria and the like can be prevented from entering the device, cleanliness and sanitation of the insulin pump can be kept easily, the service life of the insulin pump is prolonged, and use safety is improved.

Ambulatory infusion pump systems can integrate a CGM sensor with an ambulatory infusion pump via a pump holder or tray that releasably holds the pump and is configured to be worn by a user. A direct electrical connection between the pump and the CGM can be facilitated by providing a sensor nest within the pump holder that causes an electrical connector on the pump to directly interface with the sensor. By combining the CGM and insulin pump into one integrated system with a direct electrical connection, a more aesthetically pleasing, convenient and reliable system is provided. Diabetes management is simplified by consolidating two essential devices into one.

A control device for managing insulin delivery in a closed-loop system. The control device comprises a computation module. The computation module is configured to receive a target basal rate indicative of a rate of a target insulin delivery rate of an insulin pump and compute a supplemental basal rate if the target basal rate is greater than a rate threshold. The supplemental basal rate is sensibly equal to a difference between the target basal rate and the rate threshold. The control device also comprises an insulin management module. The insulin management module is configured to determine a recommendation value of a control parameter of the insulin pump. The recommendation value is based on the supplemental basal rate multiplied by a time period. The control device comprises a communication module. The communication module is configured to send the recommendation value to the insulin pump.

Systems, computer programs, devices, and methods that enable coordination across multiple devices of the mobile ecosystem. In one embodiment, smart glasses detect when a user is about to eat food or take a drink and capture the consumable and portion. The data is recorded in a “morsel track” for health activity analysis. Low-fidelity captures provide preliminary recognition, while higher-fidelity captures are selectively invoked for definitive classification. Machine-learning logic generates predicted metabolic responses, such as real-time glucose trends, based on the recorded events. Predicted responses may dynamically adjust the operation of continuous glucose monitors, heart-rate sensors, or other biomedical devices. In some embodiments, the system triggers a pharmaceutical dispenser, such as an insulin pump, inhaler, or transdermal patch, to provide closed-loop therapeutic intervention in real time.

The invention discloses a metal wire paying-off torsion releasing mechanism which is suitable for machining of precise metal wires such as insulin pump wires. The device comprises a storage device, a tensioning device, a guiding device and a torsion releasing device. The core of the torsion releasing device is as follows: a first part is provided with spaced grooves and convex blocks, a second part is correspondingly provided with accommodating grooves and concave blocks, and the first part and the second part are staggered and meshed to form an S-shaped channel for a metal wire to pass through; the pneumatic adjusting assembly drives the two parts to move relatively, and the channel gap is adjusted and controlled. The tensioning device stabilizes tension, the guiding device accurately guides the metal wire, and the position adjusting device can adjust the space posture in multiple directions. The mechanism realizes controllable torsion release through the S-shaped channel and pneumatic adjustment, solves the problems of poor controllability, incomplete release and low efficiency in the prior art, has the advantages of high processing efficiency, thorough release, high automation degree and high adaptability, and ensures the precision of precision machining.

This invention relates to the field of medical device technology, specifically to a clutch structure for an insulin pump. The structure includes a base, a reservoir fixedly connected to the base, a piston plate vertically sliding within the reservoir along its width, a lead screw fixedly connected to the bottom of the piston plate, the lead screw penetrating the bottom wall of the reservoir and sliding vertically against the bottom wall; a sleeve slidably and rotatably sleeved around the lead screw, a rotating sleeve fixedly connected to the top of the sleeve, and symmetrically hinged half-nuts on the rotating sleeve, each half-nut threadedly engaging with the lead screw; a bracket fixedly connected to the base, the bracket rotatably engaging with the rotating sleeve. This invention, through the design of the half-nuts, automatically adjusts the engagement state between the half-nuts and the lead screw by rotating the rotating sleeve, facilitating rapid drug filling while preventing wear on the threads of the lead screw and half-nuts, effectively ensuring the device's performance and extending its service life.

The invention discloses an insulin pump control method and system based on blood glucose data, and relates to the technical field of insulin infusion control, and the method comprises the steps: obtaining real-time blood glucose sequence data and historical infusion record data, and carrying out the preprocessing; constructing an insulin pharmacokinetic attenuation model to calculate an in-transit insulin residual activity value; inputting the standardized blood glucose time series data into a Bayesian neural network prediction model to generate prediction uncertainty distribution parameters; calculating a prediction confidence index according to the prediction variance and comparing the prediction confidence index with a threshold value to obtain a confidence judgment result; selecting a dose optimization strategy or a conservative control strategy according to a confidence coefficient judgment result to calculate an insulin infusion dose; infusion is executed, and historical records are updated; the prediction uncertainty is quantified through the Bayesian neural network, the in-transit insulin activity is accurately modeled in combination with the pharmacokinetic model, and the control strategy is dynamically switched according to the confidence, so that the control error amplification caused by prediction misjudgment is effectively avoided, and the delayed hypoglycemia caused by the insulin superposition effect is prevented.

The invention discloses an insulin pump control system, which belongs to the technical field of medical equipment and comprises a multi-modal data acquisition module, a hierarchical prediction control module, an intelligent infusion module, a safety redundancy module, a data encryption transmission module and a user interaction module. The multi-modal data acquisition module simultaneously acquires physiological parameters, environmental parameters and behavior parameters, the hierarchical prediction control module outputs a predicted blood glucose value based on an LSTM neural network, the intelligent infusion module dynamically adjusts the insulin infusion rate according to a prediction result, and the safety redundancy module performs mutual inspection through double controllers. If monitoring is abnormal, triggering sound-light alarm and stopping insulin infusion. The insulin pump control system aims at solving the technical problems that an existing system is incomplete in parameter coverage and weak in prediction capacity, and accurate prediction of blood glucose, dynamic adaptation infusion and full-link data safety control are achieved.